International treatment of OCD variable and not in accordance with guidelines
A review of the management of obsessive compulsive disorder (OCD) has concluded that management guidelines are not fully implemented and clinical practice varies between countries.
Statistics on medication, psychological therapies and novel therapies used to treat OCD in 19 centres of excellence in 15 countries in Europe, North and South America, Australia, China and Japan revealed significant variation in the use and accessibility of preventive measures for OCD. Fluoxetine (13%) and fluvoxamine (12%) were the SSRIs most frequently prescribed and risperidone (7%) and aripiprazole (7%) the most commonly used antipsychotics. The use of neurostimulation techniques (transcranial magnetic stimulation, deep brain stimulation, gamma knife surgery, psychosurgery) was reported by less than one per cent of the centres. The authors call for guidelines to be updated to reflect clinical practice more closely.